Grant SC - Search Results

1

Phase I study of green tea extract in patients with advanced lung cancer.

Laurie SA, Miller VA, Grant SC, Kris MG, Ng KK. Laurie SA, et al. Among authors: grant sc. Cancer Chemother Pharmacol. 2005 Jan;55(1):33-8. doi: 10.1007/s00280-004-0859-1. Epub 2004 Aug 7. Cancer Chemother Pharmacol. 2005. PMID: 15309507 Clinical Trial.

2

Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy.

Miller VA, Rigas JR, Pisters KM, Grant SC, Pfister DG, Heelan RT, Kris MG. Miller VA, et al. Among authors: grant sc. Am J Clin Oncol. 1995 Aug;18(4):303-6. doi: 10.1097/00000421-199508000-00007. Am J Clin Oncol. 1995. PMID: 7625371 Clinical Trial.

3

New antineoplastic agents in lung cancer 1988-1993.

Grant SC, Kris MG. Grant SC, et al. Cancer Treat Res. 1995;72:323-47. Cancer Treat Res. 1995. PMID: 7702990 Review. No abstract available.

4

New chemotherapeutic agents for non-small cell lung cancer.

Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG. Miller VA, et al. Among authors: grant sc. Chest. 1995 Jun;107(6 Suppl):306S-311S. doi: 10.1378/chest.107.6_supplement.306s. Chest. 1995. PMID: 7781411 Review.

5

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer.

Miller VA, Rigas JR, Francis PA, Grant SC, Pisters KM, Venkatraman ES, Woolley K, Heelan RT, Kris MG. Miller VA, et al. Among authors: grant sc. Cancer. 1995 Feb 15;75(4):968-72. doi: 10.1002/1097-0142(19950215)75:4<968::aid-cncr2820750411>3.0.co;2-y. Cancer. 1995. PMID: 7842417 Clinical Trial.

6

Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy.

Grant SC, Kris MG, Gralla RJ, Clark RA, Tyson LB. Grant SC, et al. Cancer Chemother Pharmacol. 1993;31(6):442-4. doi: 10.1007/BF00685032. Cancer Chemother Pharmacol. 1993. PMID: 8453682

7

Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer.

Miller VA, Rigas JR, Tong WP, Reid JR, Pisters KM, Grant SC, Heelan RT, Kris MG. Miller VA, et al. Among authors: grant sc. Cancer Chemother Pharmacol. 1997;40(5):415-8. doi: 10.1007/s002800050679. Cancer Chemother Pharmacol. 1997. PMID: 9272118 Clinical Trial.

8

The development of docetaxel (Taxotere) in non-small cell lung cancer.

Kris MG, Miller VA, Ng KK, Grant SC. Kris MG, et al. Among authors: grant sc. Semin Oncol. 1997 Aug;24(4 Suppl 14):S14-1-S14-4. Semin Oncol. 1997. PMID: 9335515 No abstract available.

9

Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.

Miller VA, Ng KK, Grant SC, Kindler H, Pizzo B, Heelan RT, von Roemeling R, Kris MG. Miller VA, et al. Among authors: grant sc. Ann Oncol. 1997 Dec;8(12):1269-71. doi: 10.1023/a:1008219125746. Ann Oncol. 1997. PMID: 9496394 Free article. Clinical Trial.

10

Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer.

Kindler HL, Kris MG, Smith IE, Miller VA, Grant SC, Krebs JB, Ross GA, Slevin ML. Kindler HL, et al. Among authors: grant sc. Am J Clin Oncol. 1998 Oct;21(5):438-41. doi: 10.1097/00000421-199810000-00003. Am J Clin Oncol. 1998. PMID: 9781595 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters